10 Results

People

  1. Poirier
    Poirier
  2. Rudin
    Rudin
  3. De Stanchina
    De Stanchina
  4. Lok
    Lok
  5. Carney
    Carney
  6. Gardner
    Gardner
  7. Kossatz
    Kossatz
  8. Pietanza
    Pietanza
  9. Reiner
    Reiner
  10. Schneeberger
    Schneeberger

Groups

  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (10)
  2. Department of Medicine (10)
  3. GSK Faculty (10)
  4. Solid Tumor Oncology Division (10)
  5. Thoracic Oncology (10)
  6. Sloan Kettering Institute Postdocs (4)
  7. Radiochemistry and Imaging Sciences Service (2)
  8. Radiology, Department of (2)
  9. Alumni (GSK) (1)
  10. Biostatistics Service (1)
  1. "small cell lung cancer"
  2. "John Poirier"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (3)
  3. Review (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (10)
  2. Department of Medicine (10)
  3. GSK Faculty (10)
  4. Solid Tumor Oncology Division (10)
  5. Thoracic Oncology (10)
  6. Sloan Kettering Institute Postdocs (4)

More Groups

People
  1. Charles Rudin (10)
  2. John Poirier (10)
  3. Elisa De Stanchina (4)
  4. Benjamin Lok (3)
  5. Brandon Carney (2)
  6. Eric Gardner (2)

More People

Years
  1. 2019 (2)
  2. 2018 (3)
  3. 2017 (1)
  4. 2016 (1)
  5. 2015 (3)
Publications
  1. Journal of Thoracic Oncology (4)
  2. Nature Communications (2)
  3. Cancer Cell (1)
  4. Nature Reviews Cancer (1)
  5. Oncogene (1)
  6. Science Translational Medicine (1)
Publishers
  1. Elsevier Inc. (4)
  2. Nature Publishing Group (4)
  3. American Association for the Advancement of Science (1)
  4. Cell Press (1)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PET imaging of [(18)F]PARP inhibitor as a pharmacodynamic biomarker of talazoparib in small cell lung cancer PDXs
    Meeting Abstract

    Lok, B.; Laird, J.; Carney, B.; Kossatz, S.; De Stanchina, E.; Reiner, T.; Poirier, J.; Rudin, C.
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Molecular subtypes of small cell lung cancer: A synthesis of human and mouse model data
    Review

    Rudin, C. M.; Poirier, J. T.; Byers, L. A.; Dive, C.; Dowlati, A.; George, J.; Heymach, J. V.; Johnson, J. E.; Lehman, J. M.; MacPherson, D.; more...
    Nature Reviews Cancer (2019)

    Fulltext@MSK | Save
  • SLFN11 expression and efficacy of PARP inhibitor therapy in extensive stage small cell lung cancer: ECOG-ACRIN 2511 study
    Meeting Abstract

    Owonikoko, T.; Dahlberg, S.; Sica, G.; Poirier, J.; Byers, L.; Rudin, C.; Wistuba, I.; Ramalingam, S.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • PARP inhibitor radiosensitization of small cell lung cancer differs by PARP trapping potency
    Meeting Abstract

    Lok, B.; Laird, J.; Ma, J.; De Stanchina, E.; Poirier, J.; Rudin, C.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Target engagement imaging of PARP inhibitors in small-cell lung cancer
    Journal Article

    Carney, B.; Kossatz, S.; Lok, B. H.; Schneeberger, V.; Gangangari, K. K.; Pillarsetty, N. V. K.; Weber, W. A.; Rudin, C. M.; Poirier, J. T.; Reiner, T.
    Nature Communications (2018)

    Fulltext@MSK | Save
  • Chemosensitive relapse in small cell lung cancer proceeds through an EZH2-SLFN11 axis
    Journal Article

    Gardner, E. E.; Lok, B. H.; Schneeberger, V. E.; Desmeules, P.; Miles, L. A.; Arnold, P. K.; Ni, A.; Khodos, I.; de Stanchina, E.; Nguyen, T.; more...
    Cancer Cell (2017)

    Fulltext@MSK | Save
  • Small cell lung cancer: Can recent advances in biology and molecular biology be translated into improved outcomes?
    Journal Article

    Bunn, P. A. Jr; Minna, J. D.; Augustyn, A.; Gazdar, A. F.; Ouadah, Y.; Krasnow, M. A.; Berns, A.; Brambilla, E.; Rekhtman, N.; Massion, P. P.; more...
    Journal of Thoracic Oncology (2016)

    Fulltext@MSK | Save
  • DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2
    Journal Article

    Poirier, J. T.; Gardner, E. E.; Connis, N.; Moreira, A. L.; de Stanchina, E.; Hann, C. L.; Rudin, C. M.
    Oncogene (2015)

    Fulltext@MSK | Save
  • A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo
    Journal Article

    Saunders, L. R.; Bankovich, A. J.; Anderson, W. C.; Aujay, M. A.; Bheddah, S.; Black, K.; Desai, R.; Escarpe, P. A.; Hampl, J.; Laysang, A.; more...
    Science Translational Medicine (2015)

    Fulltext@MSK | Save
  • RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
    Journal Article

    Niederst, M. J.; Sequist, L. V.; Poirier, J. T.; Mermel, C. H.; Lockerman, E. L.; Garcia, A. R.; Katayama, R.; Costa, C.; Ross, K. N.; Moran, T.; more...
    Nature Communications (2015)

    Fulltext@MSK | Save